一个案例报告:长时间局部应用诺尼 (Morinda citrifolia) 药物诱导的肝损伤
Charles J Kim1,2, Diego Duran Baez1, Lenura Ziyadin1
1Department of Medicine, Mount Sinai South Nassau, Oceanside, NY, USA.
Journal of investigative medicine high impact case reports
|March 10, 2026
概括
局部不含尼的止痛乳液在患者中引起了药物诱导的肝损伤. 这一案例凸显了当前未经描述的局部 (Morinda citrifolia) 配方的潜在肝毒性风险.
科学领域:
- 草药是一种草药.
- 肝病学 肝病学是一种肝病学.
- 毒理学 毒理学 毒理学
背景情况:
- 诺尼 (Morinda citrifolia) 是一种流行的草本产品,具有抗氧化和抗炎性质,可用于各种配方.
- 口服诺尼产品的肝毒性很少见,并且以前没有记录过局部诺尼暴露的肝损伤.
研究的目的:
- 报告药物诱导性肝损伤 (DILI) 的病例,与局部含有 noni 的止痛有关.
- 调查局部 noni 配方的潜在肝毒性风险.
主要方法:
- 一个60岁的男性患有胆固醇性肝损伤的病例报告.
- 诊断评估排除了肝病的病毒性,自身免疫性和代谢性原因.
- 将肝损伤归因于长时间使用局部含有非的止痛.
主要成果:
- 患者出现了黄,,黑色尿液和胆固醇性肝酶的升高.
- 在排除其他病因后,肝损伤归因于局部的诺尼奶油.
- 肝功能测试在停止使用noni产品后的6个月内得到解决.
结论:
- 局部的noni配方可以引起药物诱导的肝损伤.
- 该机制可能涉及以 antraquinone 为媒介的氧化应激和线粒体功能障碍.
- 需要进一步的研究,以了解局部 noni 的全身吸收和肝毒性风险.
相关概念视频
Drug Toxicity: Dose-Dependent Reactions
99
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
99
Drug Toxicity: Overview
114
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
114
Drug toxicity: Idiosyncratic Reactions
103
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
103
Drug Toxicity: Risk factors
88
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
88
Drug Toxicity: Allergic Reactions
85
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
85
Inflammatory Bowel Disease I: Ulcerative Colitis
1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K


